- Home
- PPBT vs UGRO Comparison
PPBT vs UGRO Comparison
Compare PPBT & UGRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPBT
- UGRO
- Stock Information
- Founded
- PPBT 2010
- UGRO 2014
- Country
- PPBT Israel
- UGRO United States
- Employees
- PPBT N/A
- UGRO N/A
- Industry
- PPBT Biotechnology: Pharmaceutical Preparations
- UGRO Industrial Specialties
- Sector
- PPBT Health Care
- UGRO Consumer Discretionary
- Exchange
- PPBT Nasdaq
- UGRO Nasdaq
- Market Cap
- PPBT 6.3M
- UGRO 5.5M
- IPO Year
- PPBT N/A
- UGRO N/A
- Fundamental
- Price
- PPBT $2.49
- UGRO $0.32
- Analyst Decision
- PPBT Strong Buy
- UGRO Strong Buy
- Analyst Count
- PPBT 1
- UGRO 1
- Target Price
- PPBT $33.00
- UGRO $3.00
- AVG Volume (30 Days)
- PPBT 22.4K
- UGRO 490.2K
- Earning Date
- PPBT 08-15-2025
- UGRO 07-15-2025
- Dividend Yield
- PPBT N/A
- UGRO N/A
- EPS Growth
- PPBT N/A
- UGRO N/A
- EPS
- PPBT N/A
- UGRO N/A
- Revenue
- PPBT N/A
- UGRO $59,985,138.00
- Revenue This Year
- PPBT N/A
- UGRO N/A
- Revenue Next Year
- PPBT N/A
- UGRO $31.25
- P/E Ratio
- PPBT N/A
- UGRO N/A
- Revenue Growth
- PPBT N/A
- UGRO N/A
- 52 Week Low
- PPBT $2.00
- UGRO $0.26
- 52 Week High
- PPBT $13.95
- UGRO $1.92
- Technical
- Relative Strength Index (RSI)
- PPBT 52.01
- UGRO 41.69
- Support Level
- PPBT $2.26
- UGRO $0.26
- Resistance Level
- PPBT $2.50
- UGRO $0.44
- Average True Range (ATR)
- PPBT 0.13
- UGRO 0.04
- MACD
- PPBT 0.00
- UGRO 0.00
- Stochastic Oscillator
- PPBT 58.82
- UGRO 28.65
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.
About UGRO urban-gro Inc.
Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.